CUSIP: 75382F106
Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
31,124,668
-
Share change
-
+299,158
-
Total reported value
-
$359,301,100
-
Put/Call ratio
-
47%
-
Price per share
-
$11.55
-
Number of holders
-
73
-
Value change
-
+$6,260,995
-
Number of buys
-
40
-
Number of sells
-
30
Quarterly Holders Quick Answers
What is CUSIP 75382F106?
CUSIP 75382F106 identifies RPTP - RAPTOR PHARMACEUTICAL CORP - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Institutional Holders of RAPTOR PHARMACEUTICAL CORP - COM (RPTP) as of Q2 2014
As of 30 Jun 2014,
RAPTOR PHARMACEUTICAL CORP - COM (RPTP) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,124,668 shares.
The largest 10 holders included
CREDIT SUISSE AG/, GOLDMAN SACHS GROUP INC, FMR LLC, ROYAL BANK OF CANADA, BlackRock Fund Advisors, State Street Corp, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, GROUP ONE TRADING, L.P., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
73
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.